Towa Pharmaceutical Co., Ltd.
TWAPF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $122,453 | $119,282 | $179,742 | $188,566 |
| - Cash | $49,576 | $35,015 | $45,471 | $29,252 |
| + Debt | $236,263 | $237,894 | $230,983 | $223,479 |
| Enterprise Value | $309,140 | $322,161 | $365,254 | $382,793 |
| Revenue | $442 | $65,149 | $65,857 | $70,333 |
| % Growth | -99.3% | -1.1% | -6.4% | – |
| Gross Profit | $159 | $23,675 | $23,985 | $25,830 |
| % Margin | 36% | 36.3% | 36.4% | 36.7% |
| EBITDA | $96 | $10,456 | $10,968 | $12,260 |
| % Margin | 21.8% | 16% | 16.7% | 17.4% |
| Net Income | $39 | $2,513 | $4,362 | $8,069 |
| % Margin | 8.7% | 3.9% | 6.6% | 11.5% |
| EPS Diluted | 0.78 | 51.05 | 88.61 | 163.92 |
| % Growth | -98.5% | -42.4% | -45.9% | – |
| Operating Cash Flow | $55 | $5,892 | $17,706 | -$2,959 |
| Capital Expenditures | -$57 | -$4,380 | -$6,827 | -$10,341 |
| Free Cash Flow | -$2 | $1,512 | $10,879 | -$13,300 |